MedTrace Logo

Effect of Regular Sildenafil on Blood Pressure and Arterial Function in Hypertension

NCT00317421 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-04-24

No results posted yet for this study

Summary

The purpose of the study is to investigate if regular treatment with sildenafil reduces blood pressure and improves blood vessel function in patients with hypertension (high blood pressure).

Conditions

Interventions

DRUG

Sildenafil citrate

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • James J Oliver, MBChB · University of Edinburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Completion
2005-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00317421 on ClinicalTrials.gov